Atara Biotherapeutics, Inc. (0HIY.L)
USD 6.16
(5.84%)
USD 6.16
(5.84%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -65.18 USD | -16.48% |
| 2022 | -55.96 USD | 38.36% |
| 2021 | -90.78 USD | 12.4% |
| 2020 | -103.63 USD | 26.91% |
| 2019 | -141.78 USD | -7.7% |
| 2018 | -131.64 USD | -3191.0% |
| 2017 | -100.03 USD | -45.45% |
| 2016 | -68.78 USD | -22.77% |
| 2015 | -55.92 USD | -51.35% |
| 2014 | -140.42 USD | -131.25% |
| 2013 | -227.09 USD | 28.89% |
| 2012 | -16.81 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -3.10 USD | 45.13% |
| 2024 Q1 | -5.75 USD | 59.59% |
| 2023 Q1 | -18.00 USD | 0.39% |
| 2023 FY | - USD | -16.48% |
| 2023 Q4 | -14.09 USD | 13.35% |
| 2023 Q3 | -16.26 USD | 4.35% |
| 2023 Q2 | -17.00 USD | 5.56% |
| 2022 Q4 | -18.07 USD | 11.98% |
| 2022 Q1 | -0.87 USD | 9.38% |
| 2022 Q2 | 0.18 USD | 120.69% |
| 2022 FY | - USD | 38.36% |
| 2022 Q3 | -20.53 USD | -11505.56% |
| 2021 Q3 | -0.90 USD | 1.1% |
| 2021 Q4 | -0.96 USD | -6.67% |
| 2021 Q1 | -0.86 USD | 9.47% |
| 2021 FY | - USD | 12.4% |
| 2021 Q2 | -0.91 USD | -5.81% |
| 2020 Q4 | -0.95 USD | -3.26% |
| 2020 Q1 | -1.20 USD | 11.76% |
| 2020 Q2 | -1.14 USD | 5.0% |
| 2020 Q3 | -0.92 USD | 19.3% |
| 2020 FY | - USD | 26.91% |
| 2019 Q2 | -1.60 USD | -11.11% |
| 2019 Q1 | -1.44 USD | 17.71% |
| 2019 FY | - USD | -7.7% |
| 2019 Q4 | -1.36 USD | -3.82% |
| 2019 Q3 | -1.31 USD | 18.13% |
| 2018 Q3 | -1.29 USD | -12.17% |
| 2018 Q1 | -1.05 USD | 8.7% |
| 2018 FY | - USD | -3191.0% |
| 2018 Q4 | -1.75 USD | -35.66% |
| 2018 Q2 | -1.15 USD | -9.52% |
| 2017 Q1 | -0.88 USD | -39.68% |
| 2017 FY | - USD | -45.45% |
| 2017 Q4 | -1.15 USD | -12.75% |
| 2017 Q3 | -1.02 USD | -8.51% |
| 2017 Q2 | -0.94 USD | -6.82% |
| 2016 Q2 | -0.66 USD | -13.79% |
| 2016 Q1 | -0.58 USD | 22.67% |
| 2016 FY | - USD | -22.77% |
| 2016 Q4 | -0.63 USD | 28.41% |
| 2016 Q3 | -0.88 USD | -33.33% |
| 2015 FY | - USD | -51.35% |
| 2015 Q2 | -0.62 USD | -47.62% |
| 2015 Q1 | -0.42 USD | 37.31% |
| 2015 Q4 | -0.75 USD | -74.42% |
| 2015 Q3 | -0.43 USD | 30.65% |
| 2014 Q2 | -0.23 USD | 55.77% |
| 2014 Q4 | -0.67 USD | -116.13% |
| 2014 FY | - USD | -131.25% |
| 2014 Q3 | -0.31 USD | -34.78% |
| 2014 Q1 | -0.52 USD | -100.0% |
| 2013 Q1 | -0.09 USD | 0.0% |
| 2013 Q3 | -0.19 USD | -90.0% |
| 2013 Q4 | -0.26 USD | -36.84% |
| 2013 FY | - USD | 28.89% |
| 2013 Q2 | -0.10 USD | -5.37% |
| 2012 FY | - USD | 0.0% |